Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom W J Huizinga

Showing results (41-50 of 519) with videos related to

Pageof 52
Sort By:
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|September 5, 2019
Shrinking Lung Syndrome: Diagnostic and Therapeutic Challenges in 3 Patients With Systemic Lupus ErythematosusJacopo Ciaffi, Maka Gegenava, Maarten K Ninaber, et al.
The Journal of Rheumatology|April 5, 2007
Acitretin-related ossificationMaarten J Rood, Sjan P M Lavrijsen, Tom W J Huizinga
Immunological Reviews|September 9, 2024
Pathogenic role of anti-nuclear autoantibodies in systemic sclerosis: Insights from other rheumatic diseasesWieke M van Oostveen, Tom W J Huizinga, Cynthia M Fehres
Arthritis Research & Therapy|April 9, 2008
Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsetsAnnette H M van der Helm-van Mil, Tom W J Huizinga
European Journal of Clinical Investigation|April 27, 2013
Platelets and autoimmunityKim L L Habets, Tom W J Huizinga, René E M Toes
Lancet (London, England)|October 29, 2002
Multiple sclerosis and type 1 diabetes in SardiniaAnton J M de Craen, Tom W J Huizinga, Rudi G J Westendorp
Immunogenetics|May 11, 2011
Genetics of rheumatoid arthritis: what have we learned?Marieke Bax, Jurgen van Heemst, Tom W J Huizinga, et al.
Journal of Managed Care & Specialty Pharmacy|May 7, 2015
Comparative Efficacy of Novel DMARDs as Monotherapy and in Combination with Methotrexate in Rheumatoid Arthritis Patients with Inadequate Response to Conventional DMARDs: A Network Meta-AnalysisFelicity Buckley, Axel Finckh, Tom W J Huizinga, et al.
Arthritis Research & Therapy|July 3, 2015
Response to 'Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis'--authors' replyIris M Markusse, Willem F Lems, Tom W J Huizinga, et al.
Journal of Autoimmunity|November 1, 2005
Redefining the HLA and RA association: to be or not to be anti-CCP positiveRené R P de Vries, Tom W J Huizinga, René E M Toes
Pageof 52

Showing results (41-50 of 519) with videos related to

Sort By:
Pageof 52
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|September 5, 2019
Shrinking Lung Syndrome: Diagnostic and Therapeutic Challenges in 3 Patients With Systemic Lupus ErythematosusJacopo Ciaffi, Maka Gegenava, Maarten K Ninaber, et al.
The Journal of Rheumatology|April 5, 2007
Acitretin-related ossificationMaarten J Rood, Sjan P M Lavrijsen, Tom W J Huizinga
Immunological Reviews|September 9, 2024
Pathogenic role of anti-nuclear autoantibodies in systemic sclerosis: Insights from other rheumatic diseasesWieke M van Oostveen, Tom W J Huizinga, Cynthia M Fehres
Arthritis Research & Therapy|April 9, 2008
Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsetsAnnette H M van der Helm-van Mil, Tom W J Huizinga
European Journal of Clinical Investigation|April 27, 2013
Platelets and autoimmunityKim L L Habets, Tom W J Huizinga, René E M Toes
Lancet (London, England)|October 29, 2002
Multiple sclerosis and type 1 diabetes in SardiniaAnton J M de Craen, Tom W J Huizinga, Rudi G J Westendorp
Immunogenetics|May 11, 2011
Genetics of rheumatoid arthritis: what have we learned?Marieke Bax, Jurgen van Heemst, Tom W J Huizinga, et al.
Journal of Managed Care & Specialty Pharmacy|May 7, 2015
Comparative Efficacy of Novel DMARDs as Monotherapy and in Combination with Methotrexate in Rheumatoid Arthritis Patients with Inadequate Response to Conventional DMARDs: A Network Meta-AnalysisFelicity Buckley, Axel Finckh, Tom W J Huizinga, et al.
Arthritis Research & Therapy|July 3, 2015
Response to 'Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis'--authors' replyIris M Markusse, Willem F Lems, Tom W J Huizinga, et al.
Journal of Autoimmunity|November 1, 2005
Redefining the HLA and RA association: to be or not to be anti-CCP positiveRené R P de Vries, Tom W J Huizinga, René E M Toes
Pageof 52